Search Results for: Cells
when cancer cells have mutated enormously, they express abnormal antigens; becoming strangers in the body. the immune system is more prone to recognize highly mutated tumors and, therefore, the chance of success of immunotherapy is higher. current immuno-oncology therapies are chekpoint inhibitors (monoclonal
antibody) and car-t cells (cytotoxic lymphocytes engeneered to recognize cancer cells). some tumors, such as: melanoma, kidney cancers, lung cancers, oesogastric cancers, head & neck cancers, bladder cancers, and some lymphomas, are more sensitive than others to immunotherapies. paolo de martin editor...
https://www.scor.com/sites/default/files/2019-hiv_cancer_immunotherapy-final.pdf